|
Volumn 51, Issue 1, 2004, Pages 90-92
|
Rosacea subtype-directed therapy
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALCOHOL;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANTIANDROGEN;
ANTIBIOTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCINEURIN INHIBITOR;
CLONIDINE;
DOXYCYCLINE;
ERYTHROMYCIN;
ISOTRETINOIN;
METRONIDAZOLE;
MINOCYCLINE;
NADOLOL;
NICOTINIC ACID;
OIL;
PIMECROLIMUS;
RETINOID;
SILICONE;
SPIRONOLACTONE;
STEROID;
SULFACETAMIDE;
SULFUR;
TACROLIMUS;
TAZAROTENE;
TETRACYCLINE;
TRIACYLGLYCEROL LIPASE;
WATER;
CLINICAL FEATURE;
DISEASE CLASSIFICATION;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG INDICATION;
EARLY DIAGNOSIS;
ENVIRONMENTAL FACTOR;
ERYTHEMA;
FACE;
GRANULOMA;
HEREDITY;
HUMAN;
IMMUNOPATHOLOGY;
LOW DRUG DOSE;
PAPULE;
PATHOGENESIS;
PRIORITY JOURNAL;
PULSED DYE LASER;
REVIEW;
ROSACEA;
SKIN MANIFESTATION;
SKIN TEMPERATURE;
STAPHYLOCOCCUS EPIDERMIDIS;
SURGICAL TECHNIQUE;
TELANGIECTASIA;
|
EID: 3042824776
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2004.03.012 Document Type: Article |
Times cited : (11)
|
References (7)
|